Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Eisai Inc.
Information provided by (Responsible Party):
Virginia Kaklamani, Northwestern University
ClinicalTrials.gov Identifier:
NCT01372579
First received: June 1, 2011
Last updated: May 14, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2018
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)